257 related articles for article (PubMed ID: 30801516)
41. Successful launch of an ABO-incompatible kidney transplantation program to overcome the shortage of compatible living donors: experience at a single center
.
Song SH; Lee J; Kim BS; Kim S; Lee JG; Jeong HJ; Kim YS; Kim MS; Kim HO; Kim SI; Huh KH
Clin Nephrol; 2017 Sep; 88(9):117-123. PubMed ID: 28679466
[TBL] [Abstract][Full Text] [Related]
42. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.
Zschiedrich S; Jänigen B; Dimova D; Neumann A; Seidl M; Hils S; Geyer M; Emmerich F; Kirste G; Drognitz O; Hopt UT; Walz G; Huber TB; Pisarski P; Kramer-Zucker A
Nephrol Dial Transplant; 2016 Apr; 31(4):663-71. PubMed ID: 26610596
[TBL] [Abstract][Full Text] [Related]
43. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
44. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
[TBL] [Abstract][Full Text] [Related]
45. ABO incompatible renal transplants and decreased likelihood for developing immune responses to HLA and kidney self-antigens.
Subramanian V; Gunasekaran M; Gaut JP; Phelan D; Vachharajani N; Santos RD; Wellen J; Shenoy S; Mohanakumar T
Hum Immunol; 2016 Jan; 77(1):76-83. PubMed ID: 26476207
[TBL] [Abstract][Full Text] [Related]
46. The significance of C4d staining with minimal histologic abnormalities.
Haas M
Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
[TBL] [Abstract][Full Text] [Related]
47. Antibody-Mediated Rejection in a Blood Group A-Transgenic Mouse Model of ABO-Incompatible Heart Transplantation.
Motyka B; Fisicaro N; Wang SI; Kratochvil A; Labonte K; Tao K; Pearcey J; Marshall T; Mengel M; Sis B; Fan X; dʼApice AJ; Cowan PJ; West LJ
Transplantation; 2016 Jun; 100(6):1228-37. PubMed ID: 27120451
[TBL] [Abstract][Full Text] [Related]
48. ABO-Incompatible Liver Transplantation - A Review of the Historical Background and Results.
Dahlgren US; Bennet W
Int Rev Immunol; 2019; 38(3):118-128. PubMed ID: 31012340
[TBL] [Abstract][Full Text] [Related]
49. Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation.
Furuya M; Yamamoto I; Kobayashi A; Nakada Y; Sugano N; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Yokoyama K; Yokoo T
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():31-4. PubMed ID: 24842819
[TBL] [Abstract][Full Text] [Related]
50. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
[TBL] [Abstract][Full Text] [Related]
51. Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis.
Lo P; Sharma A; Craig JC; Wyburn K; Lim W; Chapman JR; Palmer SC; Strippoli GF; Wong G
Transplantation; 2016 Apr; 100(4):933-42. PubMed ID: 26425876
[TBL] [Abstract][Full Text] [Related]
52. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
Genberg H; Kumlien G; Wennberg L; Berg U; Tydén G
Transplantation; 2008 Jun; 85(12):1745-54. PubMed ID: 18580466
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of ABO-incompatible kidney transplantation in the United States.
Montgomery JR; Berger JC; Warren DS; James NT; Montgomery RA; Segev DL
Transplantation; 2012 Mar; 93(6):603-9. PubMed ID: 22290268
[TBL] [Abstract][Full Text] [Related]
54. Subclinical Antibody-mediated Rejection After Kidney Transplantation: Treatment Outcomes.
Parajuli S; Joachim E; Alagusundaramoorthy S; Blazel J; Aziz F; Garg N; Muth B; Mohamed M; Mandelbrot D; Zhong W; Djamali A
Transplantation; 2019 Aug; 103(8):1722-1729. PubMed ID: 30507740
[TBL] [Abstract][Full Text] [Related]
55. Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report.
Langhorst C; Ganner A; Schneider J; Prager EP; Walz G; Pisarski P; Jänigen B; Zschiedrich S
Transplant Proc; 2021 Apr; 53(3):848-855. PubMed ID: 33041078
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period.
Yoon HE; Kim SH; Kim JY; Oh EJ; Park SC; Choi BS; Choi YJ; Moon IS; Kim YS; Yang CW
Clin Transplant; 2009; 23(6):812-8. PubMed ID: 19191803
[TBL] [Abstract][Full Text] [Related]
57. Modelling acute antibody-mediated rejection of human kidney transplants using ex-vivo warm machine perfusion.
Chandak P; Phillips BL; Bennett D; Uwechue R; Kessaris N; Shaw O; Maggs T; Woodford L; Veniard D; Perera R; Parmar K; Hunt BJ; Callaghan C; Dorling A; Mamode N
EBioMedicine; 2022 Dec; 86():104365. PubMed ID: 36427468
[TBL] [Abstract][Full Text] [Related]
58. Desensitization with the Use of an Antibody Removal-Free Protocol in ABO-Incompatible Kidney Transplant Recipients with a Low Anti-A/B Antibody Titer.
Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T
Transplant Proc; 2018 May; 50(4):982-986. PubMed ID: 29731097
[TBL] [Abstract][Full Text] [Related]
59. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients.
Bagnasco SM; Zachary AA; Racusen LC; Arend LJ; Carter-Monroe N; Alachkar N; Nazarian SM; Lonze BE; Montgomery RA; Kraus ES
Transplantation; 2014 Feb; 97(4):440-5. PubMed ID: 24531821
[TBL] [Abstract][Full Text] [Related]
60. Chronic Active Antibody-Mediated Rejection Is Associated With the Upregulation of Interstitial But Not Glomerular Transcripts.
Trailin A; Mrazova P; Hruba P; Voska L; Sticova E; Slavcev A; Novotny M; Kocik M; Viklicky O
Front Immunol; 2021; 12():729558. PubMed ID: 34616398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
